Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Pauline Hamon, Graham J. Britton et al.|Immunity|2020Cited by 1.8k
Treatment of Progressive Multifocal Leukoencephalopathy Associated with NatalizumabWerner Wenning, Ralf Gold, Aiden Haghikia et al.|New England Journal of Medicine|2009Cited by 178
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington diseaseElahe Taherzadeh-Fard, Larissa Arning, Carsten Saft et al.|Molecular Neurodegeneration|2011Cited by 134
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohortA.K. Trampe, Andrew Chan, Claudia Hemmelmann et al.|Neurology|2012Cited by 128
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Manuel Comabella, Jordi Río et al.|Brain|2015Cited by 110